You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoma, Extranodal NK-T-Cell

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma

Terminated
  • Metastatic Colon Adenocarcinoma
  • +27 more
  • San Francisco, California
  • +1 more
Jan 5, 2023

Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,

Recruiting
  • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 6, 2023

Myelodysplastic Syndrome, Recurrent Myelodysplastic Syndrome, Refractory Myelodysplastic Syndrome Trial in Philadelphia

Recruiting
  • Myelodysplastic Syndrome
  • +2 more
  • Navitoclax
  • +6 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Feb 2, 2023

Lymphoma Trial in United Kingdom (biological, drug, radiation)

Terminated
  • Lymphoma
  • rituximab
  • +5 more
  • Manchester, England, United Kingdom
  • +4 more
Dec 16, 2021

Core Biomarkers of Alzheimer's Disease

Recruiting
  • Alzheimer's Disease
    • Beijing, Beijing, China
      Xuanwu Hospital of Capital Medical University
    Aug 18, 2021

    Penile Cancer, Margin Assessment Trial in Groningen (Cetuximab-IRDye800CW)

    Recruiting
    • Penile Cancer
    • Margin Assessment
    • Groningen, Netherlands
      University Medical Center Groningen
    May 16, 2022

    Esophageal Squamous Cell Carcinomas Trial in Beijing (SI-B001, Irinotecan)

    Recruiting
    • Esophageal Squamous Cell Carcinomas
    • Beijing, Beijing, China
      Beijing Cancer Hostital
    Mar 14, 2022

    NSCLC Trial in San Antonio (bexmarilimab (FP-1305), Pembrolizumab)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • San Antonio, Texas
      Mays Cancer Center, UT Health San Antonio
    May 13, 2022

    Non Small Cell Lung Cancer, Liquid Biopsy, Tyrosine Kinase Inhibitor Trial in Rotterdam

    Recruiting
    • Non Small Cell Lung Cancer
    • +2 more
      • Rotterdam, Netherlands
        Erasmus MC
      Feb 2, 2022

      Hepatocellular Carcinoma, Liver Cancer, Liver Tumors Trial in Xi'an (ET1402L1-ARTEMIS™ T cells -IV, ET1402L1-ARTEMIS™ T cells

      Completed
      • Hepatocellular Carcinoma
      • +3 more
      • ET1402L1-ARTEMIS™ T cells -IV
      • +2 more
      • Xi'an, China
        The First Affiliated Hospital of Xi'an Jiaotong University
      Mar 26, 2021

      Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Australia, United States (ABT-199)

      Completed
      • Chronic Lymphocytic Leukemia
      • Non-Hodgkin Lymphoma
      • Tucson, Arizona
      • +9 more
      Feb 10, 2022

      NSCLC Trial in Ann Arbor (Pevonedistat, Docetaxel)

      Terminated
      • Non-small Cell Lung Cancer
      • Ann Arbor, Michigan
        University of Michigan Comprehensive Cancer Center
      Dec 16, 2021

      Predictors and Outcomes in Patients With Sickle Cell Disease

      Recruiting
      • Sickle Cell Disease
        • Memphis, Tennessee
        • +1 more
        Jul 8, 2022

        Partial Thickness Rotator Cuff Tear Trial in United States (Adipose Derived Regenerative Cells, Corticosteroid)

        Enrolling by invitation
        • Partial Thickness Rotator Cuff Tear
        • Adipose Derived Regenerative Cells
        • Corticosteroid
        • Phoenix, Arizona
        • +12 more
        Nov 17, 2022

        EBV Lymphomas, EBV-associated Malignancies Trial (EBV-specific T-cells)

        Withdrawn
        • EBV Lymphomas
        • EBV-associated Malignancies
        • EBV-specific T-cells
        • (no location specified)
        Jun 9, 2020

        International REgistry of COnservative or Radical Treatment of

        Recruiting
        • Kidney Cancer
        • Partial Nephrectomy (PN)
        • +3 more
        • Los Angeles, California
        • +36 more
        May 2, 2022

        Isocitrate Dehydrogenase Gene Mutation Trial in Spain, United States (HMPL-306)

        Recruiting
        • Isocitrate Dehydrogenase Gene Mutation
        • Atlanta, Georgia
        • +6 more
        Feb 22, 2022

        Carcinoma, Renal Cell Trial in Dallas (Fitbit Versa)

        Terminated
        • Carcinoma, Renal Cell
        • Fitbit Versa
        • Dallas, Texas
          University of Texas Southwestern Medical Center
        Feb 21, 2022

        Survivors of Transplant, CREST Study

        Recruiting
        • Acute Lymphoblastic Leukemia
        • +6 more
        • Bioelectric Impedance Analysis
        • +7 more
        • Duarte, California
          City of Hope Comprehensive Cancer Center
        Mar 7, 2022

        Small Cell Lung Cancer Trial in Worldwide (ABBV-011, Budigalimab)

        Recruiting
        • Small Cell Lung Cancer
        • Birmingham, Alabama
        • +32 more
        Oct 5, 2022

        Lung Cancer Trial in Worldwide (osimertinib)

        Active, not recruiting
        • Lung Cancer
        • Aarhus, Denmark
        • +9 more
        Apr 6, 2022

        Squamous Cell Carcinoma of the Head and Neck Trial (Xevinapant, Placebo, cetuximab)

        Not yet recruiting
        • Squamous Cell Carcinoma of the Head and Neck
        • (no location specified)
        Jul 3, 2023

        Type 1 Diabetes Trial in Idaho Falls, Seattle (Liraglutide, Golimumab)

        Completed
        • Type 1 Diabetes Mellitus
        • Idaho Falls, Idaho
        • +1 more
        Jan 21, 2022

        Acute Myeloid Leukemia, Lymphoblastic Leukemia, Acute Leukemia Trial in Chicago (IM-TMI (3Gy), IM-TMI (6Gy), IM-TMI (9Gy))

        Completed
        Has Results
        • Acute Myeloid Leukemia
        • +4 more
        • IM-TMI (3Gy)
        • +3 more
        • Chicago, Illinois
          University of Illinois at Chicago
        May 18, 2021

        NSCLC Trial in Lausanne (Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine), Low dose

        Recruiting
        • Non-small Cell Lung Cancer
        • Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine)
        • Low dose cyclophosphamide
        • Lausanne, Vaud, Switzerland
          CHUV Oncology Department
        Jan 17, 2022